Trump named Dr. Anne Schwartz as the next director of the CDC, signaling a shift toward a science‑driven leadership after years of politicized oversight. The announcement appeared on social media, where the former president praised Schwartz as a “STAR” and promised to restore the agency’s scientific integrity.

The decision follows criticism from CDC officials like former chief medical officer Debra Houry, who said the agency’s current head, Dr. Katherine Kennedy, had failed to grant staff autonomy. Houry cited past conflicts that stifled staffing and policy choices, echoing concerns that the agency’s scientific mission remains compromised.

Schwartz’s record includes nationwide COVID‑19 vaccine rollout and mandates for military personnel. Critics such as Aaron Siri, Kennedy’s close ally, warned that her history of enforcing vaccine mandates could undermine the CDC’s objectivity. Siri argued that her “rights‑crushing” approach signals a potential clash with public health ethics.

The appointment faces scrutiny from both sides of the aisle. While supporters argue that a medically trained director will restore credibility, detractors fear political interference may persist. The outcome will determine whether the CDC can refocus on data‑driven public health or remain mired in controversy.